Select Page

Here are commemorative photos from our event. Thank you to all the speakers and participants for making our 2018 Immunogenicity and Tolerance seminar a successful one! We will see you next year!


This seminar will center around current translational research in the fields of immunogenicity and tolerance, with case studies touching on vaccines and biologics.

To date, the committee has confirmed the attendance of the following speakers:

 Tom Ottenhoff, MD, PhD (Leiden University Medical Center)

New vaccination and therapeutic strategies against bacterial infectious diseases

Rene Raeven, PhD (Intravacc)

Effect of vaccine composition and immunization route on induction of innate immune responses and adaptive immunity against Bordetella pertussis

Rebecca Ashfield, PhD (Oxford University)

RH5: a candidate vaccine for blood stage P falciparum malaria

Andrew Godkin, MD (Institute of Infection and Immunity, School of Medicine, Cardiff University)

The role of the oncofetal antigen 5T4-specific CD4+ T cells in colorectal cancer

 Vibha Jawa, PhD (Merck)

Mechanisms behind immune response to minor impurities and their ability to break tolerance

Naomi Benne, MSc (Leiden Academic Centre for Drug Research)

Anionic 1,2-Distearoyl-sn-glycero-3-phosphoglycerol (DSPG) liposomes induce antigen-specific regulatory T cells and prevent atherosclerosis in mice

Willem van Eden, MD, PhD (Utrecht University)

Tolerogenic Dendritic cells as therapy for Rheumatoid Arthritis

You may view the full conference program here.

Interested in attending this seminar? Please register for the event here.

This is a not-for-profit event. All registration and sponsorship fees will be allocated to the cost of hosting the seminar.

A special thank you to our

Gold sponsor: 

Gold sponsor:

Gold sponsor:

Silver sponsor:

For more information, please contact Sarah Moniz at smoniz@epivax.com.